Rob A Vermond
Overview
Explore the profile of Rob A Vermond including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
200
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rienstra M, Geelhoed B, Yin X, Siland J, Vermond R, Mulder B, et al.
PLoS One
. 2016 Nov;
11(11):e0165828.
PMID: 27832125
Background: Risk prediction of atrial fibrillation (AF) is of importance to improve the early diagnosis and treatment of AF. Latent class analysis takes into account the possible existence of classes...
2.
Vermond R, Geelhoed B, Rienstra M
J Am Coll Cardiol
. 2016 Apr;
67(14):1754-5.
PMID: 27056785
No abstract available.
3.
Vermond R, Geelhoed B, Verweij N, Tieleman R, van der Harst P, Hillege H, et al.
J Am Coll Cardiol
. 2015 Aug;
66(9):1000-7.
PMID: 26314526
Background: Important improvements have been made in treatment of diseases associated with atrial fibrillation (AF), such as hypertension, myocardial infarction, and heart failure. Incidence rates and risk factors may have...
4.
Vermond R, Van Gelder I, Crijns H, Rienstra M
Circulation
. 2015 Apr;
131(21):1824-6.
PMID: 25918128
No abstract available.
5.
Vermond R, Crijns H, Tijssen J, Alings A, van den Berg M, Hillege H, et al.
Europace
. 2014 Jun;
16(10):1417-25.
PMID: 24938627
Aims: Symptoms and symptom burden have a central place in diagnosis and management of atrial fibrillation (AF). The aim of the present study is to investigate whether severity of AF...
6.
Rienstra M, Vermond R, Crijns H, Tijssen J, Van Gelder I
Heart Rhythm
. 2014 Mar;
11(6):939-45.
PMID: 24632222
Background: Symptoms are a major driver for patients with atrial fibrillation (AF) to seek medical attention and are important to titrate AF therapies. However, a large proportion of patients with...
7.
van Dijk A, Vermond R, Krijnen P, Juffermans L, Hahn N, Makker S, et al.
Eur J Clin Invest
. 2010 Sep;
40(10):893-902.
PMID: 20854280
Background: Clusterin (Apolipoprotein J), a plasma protein with cytoprotective and complement-inhibiting activities, localizes in the infarcted heart during myocardial infarction (MI). Recently, we have shown a protective effect of exogenous...
8.
van Dijk A, Krijnen P, Vermond R, Pronk A, Spreeuwenberg M, Visser F, et al.
Apoptosis
. 2009 May;
14(6):753-63.
PMID: 19421861
During acute myocardial infarction (AMI), ischemia leads to necrotic areas surrounded by border zones of reversibly damaged cardiomyocytes, showing membrane flip-flop. During reperfusion type IIA secretory phopholipase A(2) (sPLA(2)-IIA) induces...